Immunotherapy

• Delayed Abscopal Response 3 Years After Robotic Stereotactic Body Radiation Therapy for Renal Cell Carcinoma: A Case Report
• Blocking LIF and PD-L1 enhances the antitumor efficacy of SBRT in murine PDAC models
• Strategies for neoantigen screening and immunogenicity validation in cancer immunotherapy (Review)
• LincNEAT1 Encoded-NEAT1-31 Promotes Phagocytosis by Directly Activating the Aurora-A-PI3K-AKT Pathway
• Targeting the kynurenine pathway in gliomas: Insights into pathogenesis, therapeutic targets, and clinical advances
• Tertiary lymphoid structures in gliomas: impact on tumour immunity and progression
• Stereotactic laser ablation for pediatric central nervous system tumors: a systematic review and meta-analysis of the literature
• Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy

Immunotherapy is a type of medical treatment that harnesses the body's own immune system to combat diseases, particularly cancer and certain autoimmune disorders. The immune system is a complex network of cells, tissues, and molecules that work together to defend the body against harmful invaders like bacteria, viruses, and abnormal cells.

Combination immunotherapy.

CAR-T cell therapy

Monoclonal Antibody

Immune Checkpoint Inhibitor and combinations

see Cancer Immunotherapy.

Glioblastoma Immunotherapy.

The immune reaction during ischemia opens new doors for advanced targeted therapeutics. Nowadays stem cell therapy has shown better results in stroke-prone individuals. Few monoclonal antibodies like natalizumab have shown a great impact on pre-clinical and clinical stroke trial studies ¹⁾.